UPDATE : Friday, February 22, 2019
AstraZeneca’s immunotherapy Imfinzi arrives in Korea
AstraZeneca’s immunotherapy Imfinzi (ingredient: durvalumab) won domestic s...
by Lee Hye-seon  |  2018-12-05 17:12
‘New combo drug could lower blood pressure early’
Amid an increase of hypertension drug prescriptions, new hypertension combi...
by Nam Doo-hyun  |  2018-12-05 14:01
Janssen’s treatment on Crohn’s disease to get coverage
Janssen Pharmaceutical said Wednesday that the Ministry of Health and Welfa...
by Lee Han-soo  |  2018-12-05 11:03
Bristol-Myers, Pfizer unveil real-world data for cardiovascular drug
Bristol-Myers Squibb and Pfizer have presented data comparing the safety an...
by Lee Han-soo  |  2018-12-04 18:31
Roche’s lung cancer treatment gets extended reimbursement
Roche Korea said Tuesday that Alecensa, its target immunotherapy for lung c...
by Lee Han-soo  |  2018-12-04 14:32
Ministry OKs trials for Genexine’s combo treatment of breast cancer
Genexine said Monday that the Ministry of Food and Drug Safety (MFDS) has a...
by Lee Han-soo  |  2018-12-04 11:44
Hugel becomes 1st Korean firm to launch BTX product in Taiwan
Hugel said Tuesday that it has received sales approval from the Taiwan Food...
by Lee Han-soo  |  2018-12-04 11:43
Pfizer’s rheumatoid arthritis drug adds indication for ulcerative colitis
Pfizer Korea said it won approval for Xeljanz Tab. 10mg (tofacitinib citrat...
by Lee Hye-seon  |  2018-12-04 11:17
Medpacto unveils clinical trial on immunotherapy at US conference
Medpacto, a subsidiary of Theregen ETEX, said Monday that it has presented ...
by Lee Han-soo  |  2018-12-04 09:27
Genexine releases clinical trial result of immunotherapeutic drug candidate
Genexine and NeoImmuneTech said Monday it has presented the results of its ...
by Lee Han-soo  |  2018-12-03 16:05
Sanofi’s acute lymphoblastic leukemia treatment continues to receive reimbursement
Sanofi Genzyme Korea said Monday that Evoltra (Ingredient: Clofarabine), a ...
by Lee Han-soo  |  2018-12-03 14:26
ABL Bio signs licensing-out agreement with TRIGR Therapeutics
ABL Bio said Friday that it has licensed out ABL001, a bispecific antibody ...
by Lee Han-soo  |  2018-12-03 14:26
Prescriptions of anticancer drugs spiked this year
Prescriptions of anticancer medicines jumped during the first 10 months thi...
by Nam Doo-hyun  |  2018-11-30 13:01
Bukwang completes phase-2b test on new diabetes drug
Bukwang Pharmaceutical said Thursday it has completed administering MLR-102...
by Park Gi-taek  |  2018-11-29 15:19
Will Lilly’s breast cancer drug work on prostate cancer?
Lilly said it would test its investigational breast cancer treatment Abemac...
by Lee Hye-seon  |  2018-11-29 15:02
Liver society recommends Gilead’s Vemlidy as 1st-line drug for hepatitis B
The Korean Association for the Study of the Liver has recommended Gilead’s ...
by Lee Han-soo  |  2018-11-29 14:54
Vietnamese health officials visit CJ Healthcare plant
A group of Vietnamese health officials visited CJ Healthcare’s Osong plant ...
by Lee Han-soo  |  2018-11-29 14:53
Abbvie’s Humira gets expanded insurance coverage
Abbvie Korea said Thursday that the Ministry of Food and Drug Safety has ex...
by Lee Han-soo  |  2018-11-29 11:55
Yuhan develops 3-drug combo for hypertension, dyslipidemia
Yuhan Corp. said it has developed a combination drug mixed Duowell (telmisa...
by Lee Hye-seon  |  2018-11-28 15:36
Gilead’s releases research results for hepatitis B treatment
Gilead Science Korea said it has presented the data on the significance of ...
by Lee Han-soo  |  2018-11-28 15:34
Back to Top